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Advanced Concepts in Pericardial 
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Takashi Murashita
1. Introduction
Pericardial diseases are common in clinical practice and include a variety of 
pathologies such as pericarditis (acute, subacute, chronic, and recurrent), pericar-
dial effusion, cardiac tamponade, constrictive pericarditis, and pericardial masses 
[1, 2]. The etiology of pericardial diseases is classified into infectious, autoimmune, 
post-myocardial infarction, and autoreactive causes. When etiology is not appar-
ent, it is classified as idiopathic. Multimodality imaging is an essential approach for 
a modern and comprehensive diagnostic evaluation [3]. The goal of this text is to 
highlight the current concepts in the clinical characteristics, presentation, diagno-
sis, and the treatment for pericardial diseases.
2. Pericarditis
2.1 Acute pericarditis
Acute pericarditis can be diagnosed with at least two of the four following 
criteria: (1) pericarditic chest pain, (2) pericardial rubs, (3) new widespread ST 
elevation or PR depression on electrocardiogram, and (4) pericardial effusion (new 
or worsening). The additional supporting findings include (1) elevation of inflam-
mation markers (C-reactive protein, erythrocyte sedimentation rate, and white 
blood cell count) and (2) evidence of pericardial inflammation shown by computed 
tomography or magnetic resonance imaging.
In developing countries, tuberculosis is the leading cause of pericarditis, and it is 
often associated with HIV infection. In developed countries, more than 80% of the 
cases are idiopathic, and the cause is often presumed as viral infection [2].
In terms of diagnosis of suspected acute pericarditis, electrocardiogram, trans-
thoracic echocardiogram, chest X-ray, and assessment of inflammation markers and 
myocardial injury are recommended as a class I indication [1].
Predictors of poor prognosis for acute pericarditis include (1) fever >38°C,  
(2) subacute onset, (3) large pericardial effusion, (4) cardiac tamponade, and (5) 
lack of response to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) after 
at least 1 week of therapy. If the patients are categorized in high risk (at least one 
risk factor of above), hospital admission is recommended. Outpatient management 
is recommended for low-risk patients.
Regarding treatment, aspirin or NSAIDs are recommended as first-line therapy 
with gastroprotection. Colchicine is also recommended as first-line therapy as an 
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adjunct to aspirin/NSAID therapy (Table 1). Evaluation of response to anti- 
inflammatory therapy is recommended after 1 week. Low-dose corticosteroids can 
be considered in cases of contraindication/failure of aspirin/NSAIDs and colchi-
cine, when an infectious cause is excluded or when there is a specific indication such 
as an autoimmune disease.
2.2 Recurrent pericarditis
Recurrent pericarditis is the most common complication of acute pericarditis, 
and it happens in 30% of patients with a first attack of acute pericarditis. Recurrent 
pericarditis is defined with a symptom-free interval of 4–6 weeks or longer after the 
first episode of acute pericarditis.
Diagnosis is established by C-reactive protein, computed tomography, and/or 
cardiac magnetic resonance imaging showing pericardial inflammation.
Commonly prescribed anti-inflammatory therapies for recurrent pericarditis are 
aspirin, ibuprofen, indomethacin, and colchicine (Table 2). Colchicine is recom-
mended for at least 6 months. In cases of incomplete response to aspirin/NSAIDs 
and colchicine, corticosteroids may be used. However, severe side effects of corti-
costeroids were reported in about 25% of patients with high oral dose of corticoste-
roids. In order to avoid systemic side effects of corticosteroids, the intrapericardial 
route has been proposed [4, 5]; however, this technique requires further investiga-
tion. Drugs such as immunoglobulin, anakinra, or azathioprine are considered 
as third-line therapy in cases of non-response to aspirin/NSAIDS, colchicine, or 
Drug Usual dosing Therapy 
duration
Tapering
Aspirin 500–1000 mg every 
6–8 hours
Weeks–months Decrease doses by 250–500 mg every 
1–2 weeks
Ibuprofen 600 mg every 8 hours Weeks–months Decrease doses by 200–400 mg every 
1–2 weeks
Indomethacin 25–50 mg every 8 hours Weeks–months Decrease doses by 25 mg every 
1–2 weeks
Colchicine 0.5 mg per day 
(<70 kg)
0.5 mg twice a day 
(≥70 kg)
At least 
6 months
Not mandatory
Table 2. 
Commonly prescribed anti-inflammatory therapy for recurrent pericarditis.
Drug Usual dosing Therapy 
duration
Tapering
Aspirin 750–1000 mg every 
8 hours
1–2 weeks Decrease doses by 250–500 mg every 
1–2 weeks
Ibuprofen 600 mg every 8 hours 1–2 weeks Decrease doses by 250–500 mg every 
1–2 weeks
Colchicine 0.5 mg per day (<70 kg)
0.5 mg twice a day 
(≥70 kg)
3 months Not mandatory
Table 1. 
Commonly prescribed anti-inflammatory therapy for acute pericarditis.
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corticosteroids. As a last resort, pericardiectomy is considered after a thorough trail 
of unsuccessful medical therapy.
C-reactive protein dosage should be considered to guide the treatment duration 
and assess the response to therapy. After the normalization of C-reactive protein, a 
gradual tapering of therapies should be considered, tailored to symptoms, stopping 
a single class of drugs at a time.
2.3 Myopericarditis
Pericarditis which has concomitant myocardial involvement is referred to as 
myopericarditis. The classical presentation of myopericarditis is chest pain with 
other signs of pericarditis, in addition to the elevation of markers of myocardial 
damage. Viral infections are the most common cause in developed countries, 
whereas infectious causes such as tuberculosis are common in developing countries.
In cases of suspected myopericarditis, coronary angiography is recommended in 
order to rule out acute coronary syndrome. Cardiac magnetic resonance is also rec-
ommended for the confirmation of myocardial involvement. Hospitalization, rest, 
and avoidance of physical activity beyond normal sedentary activities are recom-
mended in nonathletes and athletes with myopericarditis for a period of 6 months.
3. Pericardial effusion and cardiac tamponade
Pericardial effusion is classified according to onset as acute, subacute, and chronic 
when lasting >3 months. The pericardial effusion, which was caused by inflamma-
tion leading to increased production of pericardial fluid, is called exudate pericardial 
effusion. On the other hand, the accumulation of pericardial fluid caused by decrease 
reabsorption due to an increase in systemic venous pressure as a result of congestive 
heart failure or pulmonary hypertension is called transudate pericardial effusion.
As of diagnosis, transthoracic echocardiography is recommended (Figure 1), 
and it can assess the size of the pericardial effusion (mild, < 10 mm; moderate, 
10–20 mm; or large, > 20 mm), distribution (circumferential or loculated), and 
hemodynamic effects.
Pericardial effusion is often associated with known or unknown medical 
conditions such as infections (viral, bacterial, and tuberculosis), cancer, connective 
Figure 1. 
The echocardiographic imaging for pericardial effusion. LA, left atrium; LV, left ventricle.
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tissue diseases, trauma, and metabolic causes (e.g., hypothyroidism). In developed 
countries, over 50% of the etiology is idiopathic, whereas tuberculosis is the leading 
etiology in developing countries.
It is recommended that the therapy of pericardial effusion is targeted at the eti-
ology. When pericardial effusion is associated with systemic inflammation, aspirin/
NSAIDs/colchicine, and treatment of pericarditis are recommended. For cardiac 
tamponade, symptomatic moderate to large pericardial effusions not responsive 
to medical therapy, and suspicion of unknown bacterial or neoplastic etiology, 
pericardiocentesis or pericardial window is indicated.
The common causes of cardiac tamponade include pericarditis, tuberculo-
sis, iatrogenesis (invasive procedure-related, post-cardiac surgery), trauma, 
and neoplasm/malignancy. The other causes include autoimmune diseases 
(systemic lupus erythematosus, rheumatoid arthritis, scleroderma), radiation, 
post-myocardial infarction, uremia, aortic dissection, bacterial infection, and 
pneumopericardium.
4. Constrictive pericarditis
Constrictive pericarditis is a result from inflammation and fibrosis of the peri-
cardium leading to diastolic dysfunction and right heart failure. Generally speak-
ing, constrictive pericarditis is irreversible, and once the diagnosis is made, surgical 
pericardiectomy is indicated in patients with symptoms of heart failure.
In Western countries, the etiology of constrictive pericarditis is mainly idiopathic, 
presumably unrecognized prior viral pericarditis. Previous cardiac surgery and 
prior mediastinal radiation therapy are becoming more popular. On the other hand, 
tuberculosis is a major cause of constrictive pericarditis in developing countries.
In constrictive pericarditis, Kussmaul sign and pericardial knock are common 
physical findings. Electrocardiogram may show low voltages, non-specific ST-T 
changes, or atrial fibrillation. Chest X-ray shows pericardial calcification in one-
third of the cases.
Figure 2. 
Cardiac magnetic resonance imaging shows thickening of the pericardium (arrow).
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For the diagnosis of constrictive pericarditis, transthoracic echocardiography 
and chest X-ray with adequate technical characteristics are recommended in all 
patients with suspected constrictive pericarditis. Echocardiography may show 
septal bounce, pericardial thickening and calcifications, respiratory variation of the 
mitral peak E velocity of >25% and variation in the pulmonary venous peak D flow 
velocity of >20%, or color M-mode flow propagation velocity > 45 cm/s. Computed 
tomography and cardiac magnetic resonance imaging are indicated as second-level 
imaging techniques to assess calcifications, pericardial thickness (3–4 mm), degree, 
and extension of pericardial involvement (Figure 2). Cardiac catheterization may 
show “dip and plateau” sign, right ventricular diastolic and left ventricular diastolic 
pressures usually equal, and ventricular independence.
The definitions and therapy of the main constrictive pericarditis are listed in Table 3.
5. Surgical treatment for pericardial disease
5.1 Pericardial window
A pericardial window is the procedure to create a communication from the peri-
cardial space to the pleural space. The purpose of this procedure is to allow a pericar-
dial effusion (usually malignant) to drain from the pericardial space into the chest 
cavity to prevent a large accumulation of pericardial fluid and cardiac tamponade.
Subxiphoid pericardial window is done by either local or general anesthesia. 
A vertical incision about 4 cm is made over the xiphoid process and upper abdo-
men. The diaphragm is dissected away from the undersurface of the sternum and 
xiphoid, fat is removed from over the pericardium, and the pericardium is opened 
under direct vision. All fluid is aspirated, and loculations may be broken up gently 
with the sucker. As large a pericardial window as possible is made by excision of 
the pericardium. Pericardial tissue and fluid are sent for bacteriologic and histo-
logic study.
Another way to do a pericardial window is via a left anterolateral approach. A 
small left anterolateral incision is made, and a simple pericardial window is created, 
usually of necessity anterior to the phrenic nerve. After evacuation of fluid, chest 
tubes are placed in the pleural space.
5.2 Pericardiectomy
Pericardiectomy is indicated in patients with symptomatic constrictive peri-
carditis, especially those patients requiring increasing doses of diuretics. It is also 
Syndrome Definition Therapy
Transient 
constriction
Reversible pattern of constriction 
following spontaneous recovery or 
medical therapy
2–3 months of empiric anti-inflammatory 
drugs
Effusive-
constrictive 
pericarditis
Failure of the right atrial pressure 
to fall by 50% or to a level below 
10 mmHg after pericardiocentesis
Pericardiocentesis followed by medical 
therapy. Surgery for persistent cases
Chronic 
constriction
Persistent constriction after 
3–6 months
Pericardiectomy, medical therapy for 
advanced cases or high risk of surgery, or 
mixed forms with myocardial involvement
Table 3. 
Definition and therapy for constrictive pericarditis.
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indicated in patients with effusive-constrictive pericarditis who do not respond to 
anti-inflammatory medications.
Pericardiectomy is typically done through median sternotomy, whereas it can 
be done via left anterolateral or bilateral thoracotomy. Complete pericardiectomy 
is defined as removal of the whole pericardium overlying the heart and proximal 
great vessels except for the pericardium posterior to the left atrium in the oblique 
sinus and variable amounts of pericardium adjacent to the phrenic nerves. Thus, the 
anterior pericardium (phrenic nerve to phrenic nerve), the diaphragmatic pericar-
dium, and a portion of the pericardium posterior to the left phrenic nerve should 
be removed. Failure to remove the pericardium from the diaphragmatic surface may 
lead to late recurrence of constrictive physiology.
Although cardiopulmonary bypass and systemic heparinization may increase the 
risk of bleeding, decompression of the heart with extracorporeal circulation is use-
ful and necessary in many patients because circulatory support facilitates dissection 
of the pericardium and allows wide manipulation of the ventricles. Further, with 
cardiopulmonary bypass, any injury to the myocardium is more easily repaired. 
Another advantage is that during cardiopulmonary bypass, the patient’s total blood 
volume is drained into the cardiotomy reservoir, and after pericardiectomy, intra-
vascular volume is adjusted to maintain adequate cardiac output and perfusion.
One of the largest number of pericardiectomy was reported from the Mayo 
Clinic [6]. They reviewed 1071 pericardiectomy operations for about 80 years. The 
etiology of constrictive pericarditis was idiopathic in 62%, post-cardiac surgery 
in 27%, and postradiation in 10% in the contemporary era. The 30-day mortality 
was 5.2% in the contemporary era and 13.5% in the historical era. The risk factors 
of overall mortality in the contemporary era were the New York Heart Association 
class III or IV, etiology of radiation or post-cardiac surgery, and the need for cardio-
pulmonary bypass.
6. Conclusions
Despite the recent advancement in diagnostic images and treatment options, 
there have been a limited number of randomized controlled studies in the field of 
pericardial disease. Therefore, contemporary management of pericardial disease 
is mainly performed empirically. Nowadays new diagnostic techniques have been 
available in the study of pericardial diseases.
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